BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37974386)

  • 21. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
    Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
    Kawazoe A; Kuwata T; Kuboki Y; Shitara K; Nagatsuma AK; Aizawa M; Yoshino T; Doi T; Ohtsu A; Ochiai A
    Gastric Cancer; 2017 May; 20(3):407-415. PubMed ID: 27629881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma.
    Yamashita S; Abe H; Kunita A; Yamashita H; Seto Y; Ushiku T
    Histopathology; 2021 Feb; 78(3):381-391. PubMed ID: 32767778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case.
    Nuevo-Gonzalez JA; Cano-Ballesteros JC; Lopez B; Andueza-Lillo JA; Audibert L
    J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S28-31. PubMed ID: 21826411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.
    Kim HS; Shin SJ; Beom SH; Jung M; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Noh SH; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Rha SY; Kim H
    Oncotarget; 2016 Jul; 7(28):44608-44620. PubMed ID: 27331626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein?
    Trompetas V; Varsamidakis N; Frangia K; Polimeropoulos V; Kalokairinos E
    Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1241-4. PubMed ID: 14560160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathological Types,Expression of Mismatch Repair Protein,Human Epidermal Growth Factor Receptor 2,and Pan-TRK,and Eostein-Barr Virus Infection in Patients With Colorectal Cancer Resected in Tibet].
    Luo HH; Huo Z; BIANbazhaxi ; Wang Q; DUObula ; NImazhuoma ; DA Z; Guo PP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):422-428. PubMed ID: 37407529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of gastric adenocarcinomas association with the Epstein-Barr virus-encoded small RNAs].
    Danilova NV; Mikhailov IA; Kalinin DV; Oleynikova NA; Chayka AV; Khomyakov VM; Kakotkin VV; Yudin MY; Vychuzhanin DV; Andreeva YY; Malkov PG
    Arkh Patol; 2022; 84(2):5-12. PubMed ID: 35417943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRISMA-Compliant Article: Clinical Characteristics and Factors Influencing Prognosis of Patients With Hepatoid Adenocarcinoma of the Stomach in China.
    Qu BG; Bi WM; Qu BT; Qu T; Han XH; Wang H; Liu YX; Jia YG
    Medicine (Baltimore); 2016 Apr; 95(15):e3399. PubMed ID: 27082614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
    Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
    Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
    Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.
    Nagai E; Ueyama T; Yao T; Tsuneyoshi M
    Cancer; 1993 Sep; 72(6):1827-35. PubMed ID: 7689918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach.
    Zhang JF; Shi SS; Shao YF; Zhang HZ
    Chin Med J (Engl); 2011 May; 124(10):1470-6. PubMed ID: 21740800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
    Gao YB; Zhang DF; Jin XL; Xiao JC
    J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical characteristics and prognosis of hepatoid adenocarcinoma of the stomach].
    Yao L; Xu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Feb; 17(2):196-200. PubMed ID: 24577778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma.
    Akazawa Y; Saito T; Hayashi T; Yanai Y; Tsuyama S; Akaike K; Suehara Y; Takahashi F; Takamochi K; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
    Hum Pathol; 2018 Aug; 78():79-88. PubMed ID: 29751042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing clinical pathological characteristics and gene expression patterns associated with hepatoid adenocarcinoma of the stomach.
    Ge DF; Wang YK; Li YY; Liao XH; Zhu CY; Jiang B; Wang SN
    Clin Transl Oncol; 2024 May; ():. PubMed ID: 38758385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of hepatoid adenocarcinoma of the stomach].
    Takahashi M; Shida T; Otsuka Y; Ogasawara T; Nakano S; Nomura S; Takahashi M; Kondo F; Miyazaki M
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):285-7. PubMed ID: 22333645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.